Details of the Drug

General Information of Drug (ID: DMICE6I)

Drug Name

TT-00420

Synonyms

UNII-WZ9TJ0L9Y8; WZ9TJ0L9Y8; SCHEMBL20266964; CC1=C2N=C(c3ccccc3Cl)c3cnc(cc3N=C2NN1)N1CCOCC1; 2230490-29-4; Pyrazolo(4,3-b)pyrido(4,3-E)(1,4)diazepine, 5-(2-chlorophenyl)-1,2-dihydro-3-methyl-8-(4-morpholinyl)-

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C20H19ClN6O
Canonical SMILES: CC1=C2C(=NN1)NC3=CC(=NC=C3C(=N2)C4=CC=CC=C4Cl)N5CCOCC5
InChI: 1S/C20H19ClN6O/c1-12-18-20(26-25-12)23-16-10-17(27-6-8-28-9-7-27)22-11-14(16)19(24-18)13-4-2-3-5-15(13)21/h2-5,10-11H,6-9H2,1H3,(H2,23,25,26)
InChIKey: DQFCVOOFMXEPOC-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 137279257
CAS Number: 2230490-29-4
TTD ID: D4VZ2A

References

1	ClinicalTrials.gov (NCT03654547) Safety of TT-00420 Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer. U.S. National Institutes of Health.